Renal II - Diuretics Flashcards
Mechanism of diuretic action:
Definition of diuretics?
Role of clinically useful diuretics?
Mechanism of diuretic action:
Diuretics increase rate of urine flow
Clinically useful diuretics also increase renal excretion of Na+ (natriuresis) along with Cl-
Mechanism of diuretic action:
Most clinical applications of diuretics are directed toward reducing ___ ___ __ by decreasing total-body NaCl content. However they modify excretion of other ___ as well as ___ __.
Mechanism of diuretic action:
Most clinical applications of diuretics are directed toward reducing extracellular fluid volume by decreasing total-body NaCl content. However, they modify excretion of other ions as well as uric acid.
Mechanism of diuretic action:
A sustained positive or negative Na+ balance is ____ with ____. Diuretics cause a sustained net ___ in total body Na+ but the time course is ___.
What is this due to? This results from?
Mechanism of diuretic action:
A sustained positive or negative Na+ balance is incompatible with life. Diuretics cause a sustained net deficit in total body Na+ but the time course is finite.
This is due to DIURETIC BREAKING which results from renal compensatory mechanisms that bring Na_ excretion in balance with Na+ intake
Mechanism of diuretic action:
What are the breaking mechanisms (aka renal compensatory mechanisms) that bring Na+ excretion in balance with intake?
Mechanism of diuretic action:
Breaking mechanisms:
Activation of SNS and RAAS
Decrease arterial BP (which reduces pressure natriuresis)
Hypertrophy of renal epithelial cells
Increased expression of renal epithelial transporters
(Possible involvement of hormones such as ANP)
Clinical applications of diuretics:
Primarily used in the treatment of?
Diuretics are primarily used in the treatment of
a. Hypertension (both chronic and acute)
b. CHF
c. Renal failure (to maintain flow or decrease damage)
d. Nephrotic syndrome
e. Cirrhosis (primarily for edema accompanying cirrhosis)
Clinical diuretic agents:
What are the different drug categories?
Drug catergories
a. Carbonic anhydrase inhibitors
b. Loop diuretics
c. Potassium sparing diuretics
d. Amiloride diuretics
e. Thiazides (and thiazide like diuretics)
Clinical diuretic agents:
Where are carbonic acid anhydrase inhibitors? Not primarily used as?
Carbonic anhydrase inhibitors are in the proximal convoluted tubule and are not primarily used as a diuretic but diuresis is a side effect
Clinical diuretic agents:
Where are loop diuretics?
Potentcy? Duration of action?
What do they inhibit?
What is its main effect?
Loop diuretics are in the thick ascending limb
They are the most potent and they are short acting
They inhibit the Na/2Cl/K triporter
They diminish the osmotic gradient
Clinical diuretic agents:
Where are potassium sparing diuretics?
K+ sparing diuretics are in the collecting duct
Clinical diuretic agents:
Where are the amiloride diuretics?
What do amiloride diuretics block?
What does spironolactone block?
Amiloride diuretics are in the collecting duct
Amiloride diuretics block Na+ uptake (Na+ channel blockers)
Spironolactone blocks aldosterone and the mineralocorticoid receptor
Clinical diuretic agents:
Where do the thiazide diuretics act?
What do they inhibit?
Potentcy?
Thiazide diuretics are in the distal convoluted tubule
They inhibit the NaCl cotransporter
They are not extremely potent but they are very effective
Clinical diuretic agents:
Function and location of osmotic diuretics?
Osmotic diuretics promote water excretion in areas of high permeability:
Proximal tubule, thin descending limb, and collecting ducts
Excretory and Renal Hemodynamic Effects:
- What classes cause increased K+ excretion?
- What drug increases excretion of Ca++? Dont use for who?
- What drugs do NOT mess with renal hemodynamics (RBF/GFR/FF/TGF)?
- CAI, Inhibitors of the NA/K/2Cl- transport, and inhibitors of the NaCl symport cause an increased excretion in K+
- Inhibitors of the Na+/2Cl/K symport increase excretion of Ca++ and its not for use in osteoporosis patients
- Inhibitors of NaCl symport, inhibitors of renal epithelial Na+ channels, and mineralocorticoid receptor antagonists dont mess with renal hemodynamics
Carbonic Anhydrase Inhibitors (CAI):
Three drugs?
Carbonic Anhydrase Inhibitors (CAI):
a. Acetazolamide
b. Dichlorphenamide
c. Methazolamide
Carbonic Anhydrase Inhibitors (CAI):
Normal mechanism of action:
- Where?
- How is sodium reabsorbed?
Carbonic Anhydrase Inhibitors (CAI):
Normal mechanism of action:
- PCT
- Na_ is reabsorbed via the Na/H ANTIporter
Carbonic Anhydrase Inhibitors (CAI):
Normal mechanism of action:
- The antiporter results in significant ___ extrusion into the PCT. What is this coupled to make?
- What is the role of carbonic anhydrase? What happens to the products?
Carbonic Anhydrase Inhibitors (CAI):
Normal mechanism of action:
- The antiporter results in significant H+ extrusion into the PCT. It is couples to HCO3-.
- Carbonic anhydraze catalyzes the cleavage of HCO3- into OH- and CO2. OH- couples with H+ to form water. CO2 diffuses into the cytoplasm of the epithelial cell
Carbonic Anhydrase Inhibitors (CAI):
Normal mechanism of action:
- Once CO2 is in the cell, what occurs?
- Where is the HCO3- then transported? What is the net result?
Carbonic Anhydrase Inhibitors (CAI):
Normal mechanism of action:
- Once in the cell, carbonic anhydrase II combines CO2 and OH- to HCO3-
- HCO3- is then cotransported with Na+ across the basolateral membrane. The net result is the reabsorption of bicarbonate and sodium via NBC1.
Carbonic Anhydrase Inhibitors (CAI):
Mechanism of action:
What is the function of Acetazolamide? Result?
Acetazolamide is going to inhibit both forms of carbonic anhydrase (the one on the apical membrane of the PCT and the one within the cell) and it results in a decreased sodium and bicarbonate absorption.
Carbonic Anhydrase Inhibitors (CAI):
Mechanism of action:
- CAIs almost completely abolish NaHCO3 reabsorption in the proximal tubule but only if they inhibit a ___ percentage of the enzyme. Why?
- What is sodium bicarbonate reabsorption linked to?
- What else do CAIs reduce secretion of? Where?
Carbonic Anhydrase Inhibitors (CAI):
Mechanism of action:
- High; need a high percentage of enzyme inhibition because there is a large excess of carbonic anhydrase in the PCT
- Water and Cl- (thus results in diuresis and decreased reabsorption of NaCl)
- CAIs reduce secretion of titratable acid in the collecting duct
Carbonic Anhydrase Inhibitors (CAI):
Effects on urinary ion secretion:
- Bicarbonate excretion and inhibition of titratable acid increases urine ____ and produces ____ ____.
- Fractional excretion of Na+ is as high as ___.
- Fractional excretion of K+ can be as much as ____.
This is due to increased delivery of ___ to the distal nephron, flow-dependent enhancement of K+ ____ in the ___ __ and activation of ____.
Carbonic Anhydrase Inhibitors (CAI):
Effects on urinary ion secretion:
- Bicarbonate excretion and inhibition of titrateable acid increases urine pH and produced metabolic acidosis
- Fractional excretion of Na+ is as high as 5% (high)
- Fractional excretion of K+ can be as much as 70%. This is due to increased delivery of Na+ to the distal nephron, flow dependent enhancement of K+ secretion in the collecting duct and activation of RAAS.
Carbonic Anhydrase Inhibitors (CAI):
Effects on urinary ion secretion:
- Effect on phosphate excretion?
- Effects of CAIs on renal excretion is ___ ___ because metabolic acidosis leads to a reduction in fitered ____.
Carbonic Anhydrase Inhibitors (CAI):
Effects on urinary ion secretion:
- Increase in phosphate excretion
- Effect of CAIs on renal excretion is self limiting because metabolic acidosis leads to a reduction in filtered bicarbonate
Carbonic Anhydrase Inhibitors (CAI):
Effects on renal hemodynamics:
Increased delivery of solutes to the ___ ___ triggers tubuloglomerular feedback, which ___ afferent arteriolar resistance and ___ RBF and ___
Carbonic Anhydrase Inhibitors (CAI):
Effects on renal hemodynamics:
Increased delivery of solutes to the macula densa triggers tubuloglomerulal feedback, which increases afferent arteriolar resistance and reduces RBF and GFR
Carbonic Anhydrase Inhibitors (CAI):
Affects CA in extrarenal tissues causing?
Carbonic Anhydrase Inhibitors (CAI):
Affects CA in extrarenal tissues causing:
- Decrease aqueous humor and IOP
- Parasthesia and somnolence; antoconvulsant
- Increase CO2 in tissue and decrease in expiration
- Reduce gastric acid secretion at high doses (but this is NOT therapeutic)
- Creation of acidosis
Carbonic Anhydrase Inhibitors (CAI):
Current applications?
Carbonic Anhydrase Inhibitors (CAI):
Current applications?
a. Open-angle glaucoma
b. Edema
c. Prophylaxis for altitude sicness
d. Correcting metabolic alkalosis
Carbonic Anhydrase Inhibitors (CAI):
Current applications:
- What are the two major indications for CAI?
- Edema: effectiveness? where does it act? Why is it not very useful long-term?
Carbonic Anhydrase Inhibitors (CAI):
Current applications:
- Glaucoma and correction of metabolic alkalosis
- This is not very effective for edema; acts at distal nephron sites; not good long-term because of the metabolic acidosis
Carbonic Anhydrase Inhibitors (CAI):
Adverse effects:
- CNS effects?
- Because these are ___ derivatives they cause similar symptoms including?
Carbonic Anhydrase Inhibitors (CAI):
Adverse effects:
- CNS only seen with very high doses
- CAIs are sulfonamide derivatives and can cause bone marrow depression, skin toxicity, sulfonamide like renal lesions, and allergic reactions
Carbonic Anhydrase Inhibitors (CAI):
More serious adverse effects can occur due to urinary alkalinization/metabolic acidosis:
- Diversion of renal ___ from urine into the circulation - this can worsen ___ _____.
- Can cause ___ formation and ureteral colic from precipitation of ____ in alkaline urine
Carbonic Anhydrase Inhibitors (CAI):
More serious adverse effects can occur due to urinary alkalinization/metabolic acidosis:
- Diversion of renal ammonia from urine into the circulation - this can worsen hepatic encephalopathy
- Can cause calculus formation and ureteral colic from precipitation of Ca2PO4 in alakine urine
Carbonic Anhydrase Inhibitors (CAI):
More serious adverse effects can occur due to urinary alkalinization/metabolic acidosis:
- Can worsen metabolic or ____ acidosis.
- Reduction of the urinary excretion rate of weak organic ___.
Carbonic Anhydrase Inhibitors (CAI):
More serious adverse effects can occur due to urinary alkalinization/metabolic acidosis:
- Can worsen metabolic or pulmonary acidosis
- Reduction of the urinary excretion rate of weak organic bases
Carbonic Anhydrase Inhibitors (CAI):
What are the two contraindications? Why?
Carbonic Anhydrase Inhibitors (CAI):
a. Hepatic cirrhosis (due to diversion of ammonia to circulation)
b. Hyperchloremic acidosis (bc it can worsen metabolic acidosis)
c. Severe COPD (bc it can worsen respiratory acidosis)
Osmotic diuretics:
These agents are ___ filtered at the glomerulus, have ___ reabsorption by the renal tubule, and are relatively ___. They cause a significant increase in?
Osmotic diuretics:
There agents are freely filtered at the glomerulus, have little reabsorption by the renal tubule, and are relatively inert. They cause a significant increase in plasma and tubular fluid osmolality